A detailed history of Hoffman, Alan N Investment Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hoffman, Alan N Investment Management holds 440 shares of VRTX stock, worth $221,078. This represents 0.1% of its overall portfolio holdings.

Number of Shares
440
Previous 440 -0.0%
Holding current value
$221,078
Previous $206,000 0.97%
% of portfolio
0.1%
Previous 0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$392.81 - $485.53 $172,836 - $213,633
440 New
440 $206,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hoffman, Alan N Investment Management Portfolio

Follow Hoffman, Alan N Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoffman, Alan N Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hoffman, Alan N Investment Management with notifications on news.